The following is dated for tomorrow but already out today... not new information on Leronlimab or CytoDyn but maybe for these three online publications (same author and maybe the publications are all via one company to a variety of readers):

http://www.pharmtech.com/preparing-meet-manuf...g-pandemic

http://www.biopharminternational.com/search/a...nlimab/all

http://www.spectroscopyonline.com/search/apac...nlimab/all